| Fibroblast growth factor receptor 3 alterations and response to PD-1/PD-L1 blockade in patients with metastatic urothelial cancer L Wang, Y Gong, A Saci, PM Szabo, A Martini, A Necchi, A Siefker-Radtke, ... European urology 76 (5), 599-603, 2019 | 105 | 2019 |
| Development and internal validation of a side‐specific, multiparametric magnetic resonance imaging‐based nomogram for the prediction of extracapsular extension of prostate cancer A Martini, A Gupta, SC Lewis, S Cumarasamy, KG Haines III, A Briganti, ... BJU international 122 (6), 1025-1033, 2018 | 98 | 2018 |
| The natural history of untreated muscle‐invasive bladder cancer A Martini, JP Sfakianos, L Renström‐Koskela, A Mortezavi, UG Falagario, ... BJU international 125 (2), 270-275, 2020 | 94 | 2020 |
| Contemporary techniques of prostate dissection for robot-assisted prostatectomy A Martini, UG Falagario, A Villers, P Dell’Oglio, E Mazzone, R Autorino, ... European urology 78 (4), 583-591, 2020 | 91 | 2020 |
| A nomogram to predict significant estimated glomerular filtration rate reduction after robotic partial nephrectomy A Martini, S Cumarasamy, AT Beksac, R Abaza, DD Eun, A Bhandari, ... European urology 74 (6), 833-839, 2018 | 89 | 2018 |
| Avoiding unnecessary magnetic resonance imaging (MRI) and biopsies: negative and positive predictive value of MRI according to prostate-specific antigen density, 4Kscore and … UG Falagario, A Martini, E Wajswol, PJ Treacy, P Ratnani, I Jambor, ... European urology oncology 3 (5), 700-704, 2020 | 87 | 2020 |
| The impact of experience on the risk of surgical margins and biochemical recurrence after robot-assisted radical prostatectomy: a learning curve study CA Bravi, A Tin, E Vertosick, E Mazzone, A Martini, P Dell'Oglio, A Stabile, ... The Journal of urology 202 (1), 108-113, 2019 | 86 | 2019 |
| Hood technique for robotic radical prostatectomy—preserving periurethral anatomical structures in the space of retzius and sparing the pouch of douglas, enabling early return … VG Wagaskar, A Mittal, S Sobotka, P Ratnani, A Lantz, UG Falagario, ... European Urology 80 (2), 213-221, 2021 | 76 | 2021 |
| External validation of the 2019 Briganti nomogram for the identification of prostate cancer patients who should be considered for an extended pelvic lymph node dissection G Gandaglia, A Martini, G Ploussard, N Fossati, A Stabile, P De Visschere, ... European urology 78 (2), 138-142, 2020 | 75 | 2020 |
| Combined use of prostate-specific antigen density and magnetic resonance imaging for prostate biopsy decision planning: a retrospective multi-institutional study using the … UG Falagario, I Jambor, A Lantz, O Ettala, A Stabile, P Taimen, HJ Aronen, ... European urology oncology 4 (6), 971-979, 2021 | 67 | 2021 |
| Defining clinically meaningful positive surgical margins in patients undergoing radical prostatectomy for localised prostate cancer A Martini, G Gandaglia, N Fossati, S Scuderi, CA Bravi, E Mazzone, ... European Urology Oncology 4 (1), 42-48, 2021 | 55 | 2021 |
| Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma A Martini, G Fallara, F Pellegrino, GO Cirulli, A Larcher, A Necchi, ... World journal of urology 39, 1369-1376, 2021 | 43 | 2021 |
| Upstaging to pT3a in patients undergoing partial or radical nephrectomy for cT1 renal tumors: a systematic review and meta-analysis of outcomes and predictive factors A Veccia, U Falagario, A Martini, M Marchioni, A Antonelli, C Simeone, ... European Urology Focus 7 (3), 574-581, 2021 | 43 | 2021 |
| Programmed death-1 or programmed death ligand-1 blockade in patients with platinum-resistant metastatic urothelial cancer: a systematic review and meta-analysis SA Niglio, R Jia, J Ji, S Ruder, VG Patel, A Martini, JP Sfakianos, ... European Urology 76 (6), 782-789, 2019 | 42 | 2019 |
| Pathological downstaging as a novel endpoint for the development of neoadjuvant chemotherapy for upper tract urothelial carcinoma A Martini, J Daza, E Poltiyelova, Z Gul, JR Heard, BS Ferket, ... BJU international 124 (4), 665-671, 2019 | 42 | 2019 |
| Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle‐invasive bladder cancer A Martini, R Jia, BS Ferket, N Waingankar, ER Plimack, SJ Crabb, ... Cancer 125 (18), 3155-3163, 2019 | 42 | 2019 |
| European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines JA Witjes, HM Bruins, A Carrión, R Cathomas, E Compérat, JA Efstathiou, ... European urology, 2023 | 36 | 2023 |
| Anatomical, surgical and technical factors influencing continence after radical prostatectomy C Arroyo, A Martini, J Wang, AK Tewari Therapeutic advances in urology 11, 1756287218813787, 2019 | 35 | 2019 |
| Prognostic implications of multiparametric magnetic resonance imaging and concomitant systematic biopsy in predicting biochemical recurrence after radical prostatectomy in … G Gandaglia, G Ploussard, M Valerio, G Marra, M Moschini, A Martini, ... European urology oncology 3 (6), 739-747, 2020 | 34 | 2020 |
| Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic score I Jambor, U Falagario, P Ratnani, IM Perez, K Demir, H Merisaari, ... Journal of Magnetic Resonance Imaging 51 (4), 1075-1085, 2020 | 33 | 2020 |
Alberto BrigantiVita-Salute San Raffaele University, Milan, ItalyVerified email at hsr.it
